Pre-exposure prophylaxis
(PrEP) is discussed as an additional HIV prevention
method targeting men who have sex with men (MSM). So far, PrEP has not been
approved in Switzerland and only little is known about the acceptability of
PrEP among MSM living in Switzerland. Given the slow uptake of PrEP among MSM
in the USA, the objectives of the study were to investigate the acceptability for
PrEP and to identify factors influencing the acceptability for this prevention
method and the willingness to adopt it.
During a 4-month period we conducted five focus group discussions with 23 consecutively sampled HIV-negative MSM aged 22-60 years living in Switzerland. We analyzed the data according to qualitative content analysis. The acceptability of PrEP varied considerably among the participants.
Some would use PrEP immediately after its introduction in Switzerland because it provides an alternative to condoms which they are unable or unwilling to use. Others were more ambivalent towards PrEP but still considered it
During a 4-month period we conducted five focus group discussions with 23 consecutively sampled HIV-negative MSM aged 22-60 years living in Switzerland. We analyzed the data according to qualitative content analysis. The acceptability of PrEP varied considerably among the participants.
Some would use PrEP immediately after its introduction in Switzerland because it provides an alternative to condoms which they are unable or unwilling to use. Others were more ambivalent towards PrEP but still considered it
- an additional or alternative protection to regular condom use,
- an option to engage in sexual activities with less worries and anxieties or
- a protection during receptive anal intercourse independently of the sexual partner's protective behaviour.
Full article at: http://goo.gl/Bjn9An
By: Gredig D1, Uggowitzer F1, Hassler B1, Weber P1, Nideröst S1.
- 1 School of Social Work , University of Applied Sciences and Arts Northwestern Switzerland , Olten , Switzerland.
- AIDS Care. 2016 Mar 13:1-4.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment